Abstract:BackgroundPrediabetes and non-alcoholic fatty liver disease precede development of type 2 diabetes; however, appropriate lifestyle interventions might help to prevent such progression. We aimed to test whether aerobic exercise training and a high-fibre diet can reduce hepatic fat content and increase insulin sensitivity in individuals with prediabetes and non-alcoholic fatty liver disease.MethodsWe did a randomised controlled trial in seven clinics in Yangpu district, Shanghai, China. We recruited individuals aged 50–65 years with impaired fasting glucose (5·6–6·9 mmol/L) or impaired glucose tolerance (2 h glucose 7·8–11·0 mmol/L) and diagnosed non-alcoholic fatty liver disease. We randomly assigned (1:1:1:1) participants to receive aerobic exercise, diet intervention, aerobic exercise plus diet intervention, or no intervention (control group) for 8 months. A computer program was used to generate the block randomisation sequence (block size 20). Progressive aerobic exercise training (60–75% intensity) was given three to five times per week in 30–60 min sessions. The diet intervention aimed to include 40% carbohydrate with a fibre intake of 18–25 g per day. The primary outcomes were hepatic fat content (assessed by proton magnetic resonance spectroscopy [1H MRS]) and insulin sensitivity (assessed by oral glucose tolerance test), analysed in the intention-to-treat population. We also examined participants' DNA samples for PNPLA3 genotypes. Ethics approval was granted by the Ethics Committee of Shanghai Institute of Nutrition (ref 2013-003), and all participants provided written informed consent. This trial is registered with the ISRCTN registry, number ISRCTN42622771.FindingsBetween June 1 and Dec 25, 2013, we screened 603 individuals, of whom 115 were eligible and randomly assigned to the exercise group (n=29), diet group (n=28), exercise plus diet group (n=29), or control group (n=29). Mean change in hepatic fat content was −24·4% (95% CI −41·7 to 7·1) in the exercise group, −23·2% (−45·1 to −1·3) in the diet group, and −47·9% (−65·8 to −30·0) in the exercise plus diet group, and 20·9% (−4·4 to 46·2) in the control group (p=0·006, p=0·002, and p<0·0001, respectively, for all intervention groups compared with the control group). Among individuals who completed the intervention, hepatic fat content decreased to normal levels (<5·6%) in ten (44%) of 23 participants in the exercise plus diet group, three (14%) of 22 participants in the exercise group, and nine (41%) of 22 participants in the diet group. However, insulin sensitivity increased significantly in the exercise plus diet group only (14%; p<0·05). No difference was found in PNPLA3 genotypes (GG, GC, and CC) among the groups.InterpretationAerobic exercise training combined with high-fibre intake can help to reduce liver fat content and increase insulin sensitivity more effectively than either exercise or increased fibre intake alone in patients with prediabetes and non-alcoholic fatty liver disease. This combined intervention should be used to improve health in these patients. Moreover, identification of patients with high hepatic fat content with novel imaging techniques (such as 1H MRS) has the potential to maximise patient benefit and minimise intervention costs.FundingChina State Sport General Administration (2013B040 and 2015B039) and Chinese Nature Science Foundation (NSFC 31571219).

Liver fat as a dietary target by Chinese Medical Nutrition Therapy (CMNT) diet for treating type 2 diabetes with non-alcoholic fatty liver disease: study protocol for a randomised controlled trial

A randomized controlled trial on the effects of the Chinese Medical Nutrition Therapy (CMNT) diet on type 2 diabetes: study protocol

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial

Effects of Aerobic Exercise and Diet Intervention on Glycaemic Control and Liver Fat Content in Men and Women Aged 50–65 Years with Prediabetes and Non-Alcoholic Fatty Liver Disease: a Multicentre, Randomised Controlled Trial

Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men – the role of gut microbiota composition: study protocol for the AELC randomized controlled trial

General Characteristics and Clinical Practices of Chinese Patients with Non-Alcoholic Fatty Liver Disease

Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial

Community-based Lifestyle Modification Programme for Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial

Effect of therapeutic lifestyle changes on patients with overweight/obesity and non-alcoholic fatty liver disease: A randomized controlled trial

Change Of Plasma Metabolites In Response To Omega-3 Fatty Acids In Chinese Patients With Type 2 Diabetes: A Double-Blinded Randomized Controlled Trial

Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial

Study on clinical effect of Yiqi Yangyin and Huoxue Prescription imposed on fatty liver in type 2 diabetes mellitus

623-P: Remission of Type 2 Diabetes by Low-Calorie Meal Replacement and Real Food–Based Diets—A Six-Month Pilot Intervention in China

Long-Term Lifestyle Interventions In Middle-Aged And Elderly Men With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China

Effect of Aerobic Exercise and Diet on Liver Fat in Pre-Diabetic Patients with Non-Alcoholic-fatty-liver-disease: A Randomized Controlled Trial

Chinese Herbal Medicine for Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial

Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis